Indaptus Therapeutics, INC. (INDP) — DEF 14A Filings

All DEF 14A filings from Indaptus Therapeutics, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (3)

Indaptus Seeks Shareholder Nod for Private Placement to Meet Nasdaq Rules — Jun 23, 2025 Risk: medium
Indaptus Therapeutics, Inc. (INDP) is holding a Special Meeting of Stockholders on July 25, 2025, at 10:00 a.m. Eastern time, at its New York City offices. The
Indaptus Therapeutics Executive Compensation Details — Apr 28, 2025 Risk: medium
Indaptus Therapeutics, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing include
Indaptus Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — Apr 26, 2024 Risk: low
Indaptus Therapeutics, Inc. (INDP) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Indaptus Therap

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX